Percentage of Penicillin Non-Susceptible S. pneumoniae in Canada: 1988-2009 Percentage of Penicillin Non-Susceptible S. pneumoniae in Canada: 1988-2009.

Slides:

Advertisements

Similar presentations

Antimicrobial Prescribing in the Management of COPD

Advertisements

HEART TRANSPLANTATION Pediatric Recipients 2010 ISHLT J Heart Lung Transplant Oct; 29 (10):

Adults ages 19–64 with individual coverage or who tried to buy it in past three years who: Total Health problem No health problem

Presenter Name(s) Issue date National Student.

Invasive Pneumococcal Disease (IPD)-2010

First cases of AIDS identified.

List of figure titles 1.Estimated percentage of people aged 20 years or older with diagnosed and undiagnosed diabetes, by age group, United States, 2005–2008.

SWEDRES 2001 Figures and Tables. 3. Use of antimicrobials.

Trends in incidence and mortality, England 1989 to 2010.

Antimicrobial resistance surveillance in Ireland Results of invasive Streptococcus pneumoniae infection (blood/CSF) surveillance (2009Q1-4) **** Data as.

The Resistance Problem PRSP = Penicillin Resistant Strep. pneumoniae QRSP = Quinolone Resistant Strep. pneumoniae MRSA = Methicillin Resistant Staph.

Choosing Antimicrobials in Special Situations. Additional considerations in making a final antibiotic selection Site of action – (Will the antibiotic.

Jennifer Ott, PharmD, BCPS Clinical Pharmacy Specialist, Infectious Diseases Eastern Maine Medical Center Bangor, ME

Overview of Use of PK-PD in Streamlining Drug Development William A. Craig Professor of Medicine University of Wisconsin.

Gonorrhea Sexually Transmitted Disease Surveillance 2008 Division of STD Prevention.

Sexually Transmitted Disease Surveillance 2011 Division of STD Prevention.

Toronto Invasive Bacterial Diseases Network  Collaborative network of all hospital and largest private microbiology laboratories in metropolitan Toronto/Peel.

Giebink – FDA – 01/2001 Otitis Media Epidemiology and Drug-Resistant Streptococcus pneumoniae G. Scott Giebink, M.D. Professor of Pediatrics and Otolaryngology.

“Emerging infections, the re-emergence of infectious diseases previously considered to be under control, and the alarming trend of antibiotic resistance….require.

PAHO Pan American Health Organization Pan American Sanitary Bureau Regional Office for the Americas for the World Health Organization.

1 Significant pairwise comparisons based on a Bonferroni overall significance level of α = Parameter estimates for the interactions were examined.

Epidemiology of invasive meningococcal disease in the Netherlands and impact of serogroup C vaccination National surveillance data (Netherlands Reference.

Evaluation of the resistance of bacterial pathogens of synopulmonary infections in children L.Chernyshova F.Lapiy National Medical Academy of Postgraduate.

Streptococcus pneumoniae Lecture 9 Summer, 2004 Demosthenes Pappagianis, MD MMI 480B.

Overview of Haemophilus influenzae and related bacteria Leonard Mayer, Ph. D. Chief, Meningitis Laboratory MVPDB/DBD/CDC 1.

Created byInformation Design A Mathematical Model for the Impact of the Conjugate Vaccine on S. pneumoniae Vaccine and Non-vaccine serotypes Robertino.

 decimals/cc-7th-fracs-to-decimals/v/converting-fractions-to-decimals-example.

Prof. Dr. Asem Shehabi Faculty of Medicine University of Jordan

Infections of the Central Nervous System. Definitions Meningitis Encephalitis. meningoencrphaLITIS.

Longitudinal Nationwide Antimicrobial Susceptibility Surveillance in Ocular Isolates: Results from Ocular TRUST 2 Penny A. Asbell, MD 1 Daniel F. Sahm,

Susceptibility Patterns over 3 years in Community-acquired Lower Respiratory Infection in the UK and Ireland R. Reynolds, D. Felmingham BSAC Working Party.

Antimicrobial Resistance in Streptococcus pneumoniae Implications for Prescription Drug Labeling John H. Powers, MD Lead Medical Officer Antimicrobial.

MALDI TOF analysis of Streptococcus pneumoniae from Cerebrospinal Fluid for the diagnosis of Acute Bacterial Meningitis Dr. R. Ravikumar, M.D., Professor.

EARS-Net data on antimicrobial resistance in Ireland Quarter st March 2016.

Ocular TRUST 3: Ongoing Longitudinal Surveillance of Antimicrobial Susceptibility in Ocular Isolates Penny A. Asbell, MD, FACS, MBA 1 ; Daniel F. Sahm,

Figure 1. Rate of antimicrobial resistance in S. pneumoniae

Figure 1. Percentage of Penicillin Non-Susceptible S

Toronto Invasive Bacterial Diseases Network

Number of S, I and R to six antibiotics

EARS-Net data on Antimicrobial Resistance in Ireland, Q

* LABORATORY-BASED SURVEILLANCE OF S. PNEUMONIAE INVASIVE DISEASE (IPD) IN CHILDREN: SEROTYPE DISTRIBUTION AND ESTIMATION OF VACCINES COVERAGE B. V. M.

Ontario’s Pneumococcal Vaccination Program Allison McGeer

Toronto Invasive Bacterial Diseases Network

Ontario Group A Streptococcal Study

C-672b First report of Group B Streptococcus Isolates with Cross-resistance to Lincosamides, Streptogramin A, and Pleuromutilins in the United States P.

at George Washington University Medical Center, Washington, DC

Table 5 Sample format for results of Streptococcus pneumoniae isolate testing in a laboratory that routinely performs only oxacillin disk tests for penicillin.

Antibiotic resistance and serotype distribution of nasopharyngeal isolates of Streptococcus pneumoniae from children in Marrakech region (Morocco) Karima.

R. Leclercq Clinical Microbiology and Infection

Ketolides: A New Class of Antibacterial Agents for Treatment of Community-Acquired Respiratory Tract Infections in a Primary Care Setting Jeffrey Paul.

P. Clarke, S. Murchan, E.G. Smyth, H. Humphreys

The State of Pneumococcal Disease Prevention

Strain features and distributions in pneumococci from children with invasive disease before and after 13-valent conjugate vaccine implementation in the.

Pneumococcal conjugate vaccines: overview of a decade from Kuwait

D.E. Low Clinical Microbiology and Infection

…monitoring trends in antimicrobial resistance in Canada

Carriage of resistant pneumococci by children in southern Israel and impact of conjugate vaccines on carriage Ron Dagan, Drora Fraser, Noga Givon, Pablo.

M. Woodhead, F. Blasi, S. Ewig, J. Garau, G. Huchon, M. Ieven, A

Percentage of Penicillin Non-Susceptible S

Figure 1. Percentage of Penicillin Non-Susceptible S

J. Garau Clinical Microbiology and Infection

Role of communicable disease control measures in affecting the spread of resistant pneumococci: the Swedish model Karl Ekdahl, Otto Cars Clinical Microbiology.

…monitoring trends in antimicrobial resistance in Canada

M. Biçmen, Z. Gülay, S.V. Ramaswamy, D.M. Musher, D. Gür

The DUEL study: a multi-center in vitro evaluation of linezolid compared with other antibiotics in the Netherlands J.W. Mouton, A.R. Jansz Clinical.

…monitoring trends in antimicrobial resistance in Canada

…monitoring trends in antimicrobial resistance in Canada

…monitoring trends in antimicrobial resistance in Canada

Fluconazole zone diameter distributions for all Candida spp

National Immunization Conference

Presentation transcript:

Percentage of Penicillin Non-Susceptible S. pneumoniae in Canada: Percentage of Penicillin Non-Susceptible S. pneumoniae in Canada: Canadian Bacterial Surveillance Network, Jun 2010 *Non-meningitis, Oral pen breakpoints used

Percentage of Penicillin* Non-Susceptible S. pneumoniae in Canada: Percentage of Penicillin* Non-Susceptible S. pneumoniae in Canada: Canadian Bacterial Surveillance Network, Jun 2010 *Non-meningitis, IV breakpoints used

Percentage of Non-susceptible Sterile Site vs Non-sterile Site Isolates of S. pneumoniae, 2009 Canadian Bacterial Surveillance Network, Jun 2010 *Non-meningitis breakpoints used, Non-meningitis (IV) for pen

Percentage of Amoxicillin Non-Susceptible S. pneumoniae in Canada: Percentage of Amoxicillin Non-Susceptible S. pneumoniae in Canada: Canadian Bacterial Surveillance Network, Jun 2010

Percentage of Non-susceptible Isolates of S. pneumoniae in Ages 64, 2009 Percentage of Non-susceptible Isolates of S. pneumoniae in Ages 64, 2009 Canadian Bacterial Surveillance Network, Jun 2010 *Non-meningitis breakpoints used, Non-meningitis (IV) for pen

Percentage of Non-susceptible Isolates of S. pneumoniae in Geographic Regions of Canada, 2009 Canadian Bacterial Surveillance Network, Jun 2010 *Non-meningitis breakpoints used

Macrolide-Resistant Pneumococci: Canadian Bacterial Surveillance Network, Canadian Bacterial Surveillance Network, Jun 2010

Fluoroquinolone-Resistant Pneumococci: Canadian Bacterial Surveillance Network, Canadian Bacterial Surveillance Network, Jun 2010 % Resistant

Fluoroquinolone-Resistant Pneumococci in Respiratory Isolates from Adults >64 years:

Serotype distribution by year: